Garcinia mangostana L. (Clusiaceae), a popular tropical fruit for its juiciness and sweetness, is an opulent fountain of prenylated and oxygenated
xanthones with a vast array of bio-activities.
Garcinone E (GE), a
xanthone derivative reported from G. mangostana, possesses cytotoxic and
aromatase inhibitory activities. The present research endeavors to investigate the hepato-protection efficaciousness of GE on
concanavalin-A (Con-A)-instigated
hepatitis. Results showed that GE pretreating noticeably diminishes both the serum indices (
transaminases, ALP, LDH, and γ-GT) and histopathological lesions of the liver. It counteracted neutrophil and CD4+ infiltration into the liver. GE furthered the Nrf2 genetic expression and its
antioxidants' cascade, which resulted in amelioration of Con-A-caused oxidative stress (OS),
lipid per-oxidative markers (4-HNE, MDA, PC) reduction, and intensified
antioxidants (TAC, SOD, GSH) in the hepatic tissue. Additionally, GE prohibited NF-ĸB (
nuclear factor kappa-B) activation and lessened the genetics and levels of downstream
cytokines (IL1β and
IL6). Moreover, the TNF-α/JNK axis was repressed in GE-treated mice, which was accompanied by attenuation of Con-A-induced apoptosis. These findings demonstrated the protective potential of GE in Con-A-induced
hepatitis which may be associated with Nrf2/HO-1 signaling activation and OS suppression, as well as modulation of the NF-κB and TNF-α/JNK/apoptosis signaling pathway. These results suggest the potential use of GE as a novel hepato-
protective agent against
autoimmune hepatitis.